Gland Pharma reported a 27.74% increase in Q3 net profit to ₹261.48 crore, up from ₹204.69 crore last year. Revenue rose 22.49% YoY to ₹1695.36 crore, with EBITDA increasing 21% YoY to ₹434.9 crore.
Recent Posts
- Gold, silver rates today: Comex gold drops $101/oz; silver falls $3.2/oz as Middle East peace talk hopes fade
- Market Trading Guide: Buy Linde India and Prime Focus on Wednesday for short term gains up to 20%. Here’s why?
- US Stocks: ImmunityBio shares drop 20% on FDA warning letter over cancer therapy claims in ad
- ‘No case made out’: Thane court grants bail to CoinDCX co-founders held for cheating
- Chemical stock gets ‘Buy’ rating from Morgan Stanley with 40% upside potential